R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for the ELITE-BTK Pivotal Trial of its MAGNITUDE Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
MOUNTAIN VIEW, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- R3 Vascular Inc.,…
Drupal CMS: Groundbreaking New Version of Drupal Detailed at DrupalCon Singapore 2024
MARINA BAY, Singapore, Nov. 6, 2024 /PRNewswire/ -- Drupal CMS, the groundbreaking package…
Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals
November 03, 2024 17:03 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia,…